Q
Quenna PMQ
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | D | 7 | 6.9 | 3.6 | 9.7 | 5 Oct 2025 |
| Tirzepatide | D | 8 | 6.3 | 3.7 | 9.0 | 16 Jul 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 |
| Arimidex (Anastrozole) | X | 1 | 9.1 | 9.1 | 9.1 | 8 Jul 2025 |
| BAM15 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 |
| BMK ethyl glycidate CAS 41232-97-7 | X | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X | 1 | 5.4 | 5.4 | 5.4 | 7 May 2025 |
| Cardiogen | X | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 |
| CJC-1295 With DAC | X | 1 | 7.0 | 7.0 | 7.0 | 7 May 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 |
| Cortagen | X | 1 | 5.1 | 5.1 | 5.1 | 13 Feb 2025 |
| Dapoxetine | X | 1 | 7.0 | 7.0 | 7.0 | 6 May 2025 |
| EPO | X | 1 | 5.7 | 5.7 | 5.7 | 25 Apr 2025 |
| GHRP-2 Acetate | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 |
| Glutathione | X | 1 | 5.5 | 5.5 | 5.5 | 7 May 2025 |
| IGF-1 LR3 | X | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X | 1 | 5.5 | 5.5 | 5.5 | 17 Dec 2024 |
| Isotretinoin | X | 1 | 5.0 | 5.0 | 5.0 | 13 Feb 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X | 1 | 7.6 | 7.6 | 7.6 | 16 Mar 2025 |
| Livagen | X | 1 | 7.1 | 7.1 | 7.1 | 28 Mar 2025 |
| MT-1 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Feb 2025 |
| N-Acetyl Epitalon Amidate | X | 1 | 5.4 | 5.4 | 5.4 | 28 Mar 2025 |
| Nitroethane CAS 79-24-3 | X | 1 | 7.8 | 7.8 | 7.8 | 14 Jan 2025 |
| Orforglipron | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 |
| Ostarine (MK-2866) | X | 1 | 7.3 | 7.3 | 7.3 | 6 May 2025 |
| Retatrutide 30mg Pen Kit | X | 1 | 7.6 | 7.6 | 7.6 | 14 Jan 2025 |
| Salbutamol | X | 1 | 6.0 | 6.0 | 6.0 | 13 Feb 2025 |
| Selank 10mg + Semax 10mg Blend | X | 1 | 7.3 | 7.3 | 7.3 | 27 Feb 2025 |
| T3 (Liothyronine) | X | 1 | 4.3 | 4.3 | 4.3 | 2 Jul 2025 |
| Tadalafil (Cialis) | X | 1 | 4.0 | 4.0 | 4.0 | 17 Dec 2024 |
| Tamoxifen (Nolvadex) Raw | X | 1 | 5.6 | 5.6 | 5.6 | 25 Apr 2025 |
| Test Enanthate | X | 1 | 7.9 | 7.9 | 7.9 | 2 Apr 2025 |
| Testosterone Decanoate Raw | X | 1 | 7.7 | 7.7 | 7.7 | 16 Mar 2025 |
| Thymalin | X | 1 | 5.9 | 5.9 | 5.9 | 2 Apr 2025 |
| Tirzepatide Oral | X | 1 | 5.8 | 5.8 | 5.8 | 24 Apr 2025 |
| Tren Base | X | 1 | 6.0 | 6.0 | 6.0 | 17 Dec 2024 |
| TrenMix 200 | X | 1 | 7.6 | 7.6 | 7.6 | 24 Apr 2025 |
| Vilon | X | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 |
| Vitamin B12 1mg/ml | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 24 May 2026 | BMK ethyl glycidate CAS 41232-97-7 | 5.3 | 5g | 5.0g | -1.0% | 98.00% | Lab A |
| 24 May 2026 | Dapoxetine | 9.6 | 100mg | 101.9mg | +1.9% | 96.95% | Lab C |
| 24 May 2026 | N-Acetyl Epitalon Amidate | 4.9 | 2mg | 1.8mg | -10.5% | 96.31% | Lab F |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 7.3 | 30mg | 33.7mg | +12.5% | 95.52% | Lab C |
| 23 May 2026 | Salbutamol | 7.0 | 25mg | 23.1mg | -7.4% | 96.33% | Lab D |
| 23 May 2026 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 6.6 | 5g | 5.5g | +10.2% | 99.91% | Lab A |
| 23 May 2026 | Thymalin | 6.2 | 50mg | 49.5mg | -1.1% | 97.09% | Lab A |
| 21 May 2026 | Tirzepatide | 3.7 | 10mg | 11.2mg | +12.0% | 98.68% | No Label / Silver Crimp / White Cap |
| 21 May 2026 | Nitroethane CAS 79-24-3 | 7.7 | 1g | 1.1g | +8.5% | 96.58% | Lab G |
| 19 May 2026 | Isotretinoin | 5.2 | 25mg | 24.6mg | -1.7% | 98.29% | Lab E |
| 19 May 2026 | MT-1 | 4.0 | 20mg | 21.6mg | +8.0% | 98.68% | Lab B |
| 17 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 7.2 | 20mg | 19.5mg | -2.5% | 95.45% | Lab E |
| 17 May 2026 | GHRP-2 Acetate | 4.3 | 2mg | 1.8mg | -9.2% | 98.45% | Lab G |
| 17 May 2026 | Vilon | 6.5 | 5mg | 5.7mg | +14.3% | 95.68% | Lab C |
| 26 Jan 2026 | Tirzepatide | 5.0 | 30mg | 35.4mg | +18.0% | 99.80% | No Label / Copper Crimp / Clear Cap |
| 26 Jan 2026 | CJC-1295 With DAC | 5.7 | 20mg | 24.6mg | +23.0% | 96.84% | Lab C |
| 26 Jan 2026 | Selank 10mg + Semax 10mg Blend | 8.9 | 5mg | 5.5mg | +10.6% | 98.70% | Lab B |
| 9 Jan 2026 | Cortagen | 4.2 | 2mg | 2.3mg | +13.9% | 97.78% | Lab G |
| 7 Jan 2026 | T3 (Liothyronine) | 4.0 | 25mg | 22.6mg | -9.4% | 95.67% | Lab G |
| 6 Jan 2026 | Livagen | 6.8 | 20mg | 20.3mg | +1.6% | 99.05% | Lab G |
| 6 Jan 2026 | Tadalafil (Cialis) | 4.0 | 20mg | 22.0mg | +10.0% | 95.71% | Lab B |
| 6 Jan 2026 | Vitamin B12 1mg/ml | 9.9 | 300mg/ml | 364.7mg/ml | +21.6% | 97.85% | Lab F |
| 1 Jan 2026 | Retatrutide | 6.3 | 10mg | 10.9mg | +9.0% | 99.70% | (no data) |
| 29 Dec 2025 | Retatrutide | 9.7 | 10mg | 10.6mg | +6.0% | 99.91% | White Label / Silver Crimp / Clear Blue Cap |
| 29 Dec 2025 | EPO | 4.9 | 30mg | 25.7mg | -14.2% | 98.03% | Lab F |
| 29 Dec 2025 | TrenMix 200 | 7.9 | 100mg/ml | 114.3mg/ml | +14.3% | 95.36% | Lab E |
| 13 Dec 2025 | Tirzepatide | 4.7 | 60mg | 67.8mg | +13.0% | 99.40% | No Label / Copper Crimp / Clear Cap |
| 13 Dec 2025 | Retatrutide | 6.8 | 20mg | 21.4mg | +7.0% | 99.70% | No Label / Copper Crimp / Clear Cap |
| 5 Dec 2025 | BAM15 | 10.0 | 100mg | 120.2mg | +20.2% | 95.98% | Lab A |
| 5 Dec 2025 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 5.0 | 250mg/ml | 225.6mg/ml | -9.7% | 99.82% | Lab F |
| 23 Nov 2025 | Tirzepatide Oral | 6.0 | 100mg | 118.5mg | +18.5% | 96.81% | Lab D |
| 17 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 | 10mg | 12.2mg | +21.5% | 98.18% | Lab C |
| 17 Nov 2025 | Tren Base | 5.7 | 200mg/ml | 179.6mg/ml | -10.2% | 95.19% | Lab A |
| 5 Nov 2025 | Cardiogen | 4.9 | 5mg | 5.2mg | +4.3% | 96.96% | Lab C |
| 5 Nov 2025 | IGF-1 LR3 | 5.4 | 30mg | 27.8mg | -7.4% | 96.39% | Lab G |
| 17 Oct 2025 | Orforglipron | 8.7 | 25mg | 29.5mg | +18.1% | 97.00% | Lab F |
| 17 Oct 2025 | Testosterone Decanoate Raw | 9.1 | 1g | 1.2g | +15.0% | 95.22% | Lab G |
| 9 Oct 2025 | Arimidex (Anastrozole) | 10.0 | 20mg | 21.9mg | +9.3% | 97.98% | Lab C |
| 9 Oct 2025 | Glutathione | 5.7 | 30mg | 30.7mg | +2.5% | 99.91% | Lab B |
| 9 Oct 2025 | Ostarine (MK-2866) | 7.6 | 100mg | 104.1mg | +4.1% | 98.38% | Lab F |
| 9 Oct 2025 | Tamoxifen (Nolvadex) Raw | 5.3 | 100g | 102.2g | +2.2% | 95.43% | Lab G |
| 9 Oct 2025 | Test Enanthate | 6.7 | 100mg/ml | 121.8mg/ml | +21.8% | 95.22% | Lab D |
| 3 Oct 2025 | Retatrutide 30mg Pen Kit | 8.3 | 50mg | 57.1mg | +14.3% | 95.83% | Lab A |
| 6 Dec 2025⚠️ | Tirzepatide | 8.0 | 30mg | 31.1mg | +3.7% | 99.95% | No Label / Silver Crimp / Clear Teal Cap |